Alexander Kolevzon
Icahn School of Medicine at Mount Sinai · Seaver Autism Center, Mount Sinai School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
14
all conditions, ClinicalTrials.gov
NIH grants tied to them
4
NIH RePORTER
Trial papers
17
PubMed author-name match
Trials
Studies that name Alexander Kolevzon as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:02 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06424366 · Approach to Dance for AutismIcahn School of Medicine at Mount Sinai · completed · Autism Spectrum Disorder · principal investigator
- Ph2NCT05187377 · A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic AutismIcahn School of Medicine at Mount Sinai · completed · Phelan-McDermid Syndrome, Autism Spectrum Disorder (ASD) · principal investigator
- Ph1/Ph2NCT04388774 · Low-Dose Ketamine in Children With ADNP SyndromeAlexander Kolevzon · completed · ADNP Syndrome · principal investigator
- Ph2NCT04003207 · Growth Hormone Treatment in Children With Phelan McDermid SyndromeSwathi Sethuram · completed · Phelan McDermid Syndrome · study director
- N/ANCT03718910 · DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.Icahn School of Medicine at Mount Sinai · completed · DDX3X, Mental Retardation, X-linked 102, Autism Spectrum Disorder · principal investigator
- N/ANCT03718923 · FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.Icahn School of Medicine at Mount Sinai · recruiting · FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features, Autism Spectrum Disorder · principal investigator
- N/ANCT03718936 · ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.Icahn School of Medicine at Mount Sinai · recruiting · ADNP, Helsmoortel-Van Der Aa Syndrome, Autism Spectrum Disorder · principal investigator
- Ph2NCT03493607 · AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid EpilepsyAlexander Kolevzon · completed · Phelan-McDermid Syndrome, Epilepsy · principal investigator
- N/ANCT03426059 · Mapping the Phenotype in Adults With Phelan-McDermid SyndromeBoston Children's Hospital · completed · Phelan-McDermid Syndrome, Autism Spectrum Disorder, Intellectual Disability · study chair
- Ph2NCT02710084 · Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid SyndromeAlexander Kolevzon · completed · Phelan-McDermid Syndrome · principal investigator
- N/ANCT02461420 · Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid SyndromeBoston Children's Hospital · active not recruiting · Phelan-McDermid Syndrome, Autism Spectrum Disorder, Intellectual Disability · study chair
- Ph2NCT01970345 · A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum DisorderIcahn School of Medicine at Mount Sinai · terminated · Autism Spectrum Disorder · principal investigator
- Ph2NCT01894958 · A Safety Study of NNZ-2566 in Patients With Fragile X SyndromeNeuren Pharmaceuticals Limited · completed · Fragile X Syndrome · principal investigator
- Ph2NCT01525901 · Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)Icahn School of Medicine at Mount Sinai · completed · 22q13 Deletion Syndrome, Phelan-McDermid Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical trial readiness for targeting neuropsychiatric manifestations in SHANK3 and SYNGAP1 pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · fiscal years 2019 to 2026 · $488,587 awarded in 2026Grant number is on one of their registry trials
- Electrophysiological Markers for Interventions in Phelan-McDermid Syndrome and Idiopathic AutismR01NS105845 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2018 to 2022 · $678,016 awarded in 2022Grant number is on one of their registry trials
- Piloting Treatment with Insulin-Like Growth Factor-1 in Phelan-McDermid SyndromeR34MH100276 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2013 to 2015 · $84,750 awarded in 2015Grant number is on one of their registry trials
- OPEN LABEL RISPERIDONE IN CHILDREN AND ADOLESCENTS WITH AUTISTIC DISORDERM01RR000071 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2008 to 2009 · $244 awarded in 2009Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:02 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- Oxytocin selectively improves empathic accuracy.Psychol Sci · 2010296 citationsRCR 9.6
- 223 citationsRCR 16.6
- Examining the Efficacy of a Family Peer Advocate Model for Black and Hispanic Caregivers of Children with Autism Spectrum Disorder.J Autism Dev Disord · 201754 citationsRCR 3.6
- Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals.Psychol Sci · 201549 citationsRCR 2.2
- A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.Pediatr Neurol · 202041 citationsRCR 2.4
- Randomized comparative trial of a social cognitive skills group for children with autism spectrum disorder.J Am Acad Child Adolesc Psychiatry · 201539 citationsRCR 2.1
- 37 citationsRCR 3.6
- The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.J Autism Dev Disord · 202035 citationsRCR 2.4
- The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome.Neurology · 202123 citationsRCR 1.6
- Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder.J Child Adolesc Psychopharmacol · 202122 citationsRCR 1.8